Nanomedicine News

RSS

Matinas BioPharma Presents Data on MAT2203 Lipid-Crystal Nano-Particle Cochleate Technology at ICAAC/ICC 2015

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections, today presented data from a preclinical study demonstrating tissue targeting and penetration potential of MAT2203, an orally-administered, encochleated formulation of the broad spectrum antifungal medication amphotericin B (AmB).

21 Sep 2015

Nanopore MinION Device Enables Rapid DNA Sequencing for Treatment of Urinary Tract Infections

Urinary tract infections (UTIs) could be treated more quickly and efficiently using a DNA sequencing device the size of a USB stick - according to research from the University of East Anglia.

21 Sep 2015

Ignyta Initiates RXDX-107 Phase 1/1b Clinical Trial of Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Ignyta, Inc., a precision oncology biotechnology company, announced today the initiation of the company’s Phase 1/1b clinical trial of RXDX-107, its next generation alkyl ester of bendamustine encapsulated in human serum albumin (HSA) to form nanoparticles.

21 Sep 2015

Injecting Gold Nanoparticles in Mammary Tissue Enhances Imaging of Early Signs of Breast Cancer

Detecting breast cancer in women with dense mammary tissues could become more reliable with a new mammogram procedure that researchers have now tested in pre-clinical studies of mice. In their report in the journal ACS Nano, they describe injecting gold nanoparticles in mammary tissue to enhance the imaging of early signs of breast cancer.

From American Chemical Society 18 Sep 2015

FDA Accepts EnGeneIC’s IND for EGFR-Targeted Nanocells Carrying Doxorubicin to Treat Recurrent Glioma

EnGeneIC Ltd., a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's investigational new drug (IND) application for using (EGFR)-EDVs loaded with doxorubicin (dox) in patients with recurrent glioma.

18 Sep 2015

Coated Silica Nanoparticles Could be used for Restorative Treatment of Sensitive Teeth

Researchers at the University of Birmingham have shown how the development of coated silica nanoparticles could be used in restorative treatment of sensitive teeth and preventing the onset of tooth decay.

18 Sep 2015

Platelet-Mimicking Nanoparticles Could Effectively Deliver Drugs to Targeted Sites

Nanoparticles disguised as human platelets could greatly enhance the healing power of drug treatments for cardiovascular disease and systemic bacterial infections. These platelet-mimicking nanoparticles, developed by engineers at the University of California, San Diego, are capable of delivering drugs to targeted sites in the body -- particularly injured blood vessels, as well as organs infected by harmful bacteria.

18 Sep 2015

NSF Awards UCLA $1 Million Grant for Quantification and Automated Characterization of Nanoparticles

Researchers at the UCLA Henry Samueli School of Engineering and Applied Science and California NanoSystems Institute (CNSI) have won a $1 million, three-year grant from the National Science Foundation for on-site and ubiquitous quantification and automated characterization of nanoparticles found in homes, workplaces and the environment.

From University of California, Los Angeles 18 Sep 2015

Novel Technique for Real-Time Observation of Bloodstream Protein Interactions with Nanoparticles

Technique developed by NUS-led team provides more precise understanding of how proteins in the bloodstream bind to nanoparticles, paving the way for better design of nanomedicines

18 Sep 2015

Researchers Secure €3.3 Million Funding to Develop Enhanced Nanoparticle Treatment Programme for Pancreatic Cancer

Researchers at the University at Buffalo, Dublin City University and Queen’s University Belfast have secured over €3.3 million to develop an enhanced treatment programme for pancreatic cancer, the fourth leading cause of cancer deaths in the world.

16 Sep 2015

Nanomedicine News

Matinas BioPharma Presents Data on MAT2203 Lipid-Crystal Nano-Particle Cochleate Technology at ICAAC/ICC 2015

Nanopore MinION Device Enables Rapid DNA Sequencing for Treatment of Urinary Tract Infections

Ignyta Initiates RXDX-107 Phase 1/1b Clinical Trial of Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Injecting Gold Nanoparticles in Mammary Tissue Enhances Imaging of Early Signs of Breast Cancer

FDA Accepts EnGeneIC’s IND for EGFR-Targeted Nanocells Carrying Doxorubicin to Treat Recurrent Glioma

Coated Silica Nanoparticles Could be used for Restorative Treatment of Sensitive Teeth

Platelet-Mimicking Nanoparticles Could Effectively Deliver Drugs to Targeted Sites

NSF Awards UCLA $1 Million Grant for Quantification and Automated Characterization of Nanoparticles

Novel Technique for Real-Time Observation of Bloodstream Protein Interactions with Nanoparticles

Researchers Secure €3.3 Million Funding to Develop Enhanced Nanoparticle Treatment Programme for Pancreatic Cancer

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting